In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer.
Journal article
Malla SB. et al, (2021), Clin Cancer Res, 27, 288 - 300
Image-based consensus molecular subtype classification (imCMS) of colorectal cancer using deep learning
Journal article
VERRILL C. et al, (2020), Gut
Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification.
Journal article
Kleeman SO. et al, (2020), Gut, 69, 1092 - 1103
The interleukin 22 pathway interacts with mutant KRAS to promote poor prognosis in colon cancer.
Journal article
McCuaig S. et al, (2020), Clin Cancer Res
TEX264 coordinates p97- and SPRTN-mediated resolution of topoisomerase 1-DNA adducts.
Journal article
Fielden J. et al, (2020), Nat Commun, 11
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study.
Journal article
Skrede O-J. et al, (2020), Lancet, 395, 350 - 360
Loss of expression of ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN
Journal article
Beggs AD. et al, (2019)
Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage.
Journal article
Glaire MA. et al, (2019), Br J Cancer
Guidelines for using sigQC for systematic evaluation of gene signatures.
Journal article
Dhawan A. et al, (2019), Nat Protoc, 14, 1377 - 1400
An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance.
Journal article
Li N. et al, (2019), Oncogenesis, 8
PIK3CA (phosphoinositide-3-kinase, catalytic, alpha polypeptide)
Journal article
Phillips J. and Domingo E., (2019), Atlas of Genetics and Cytogenetics in Oncology and Haematology
POLD1 (DNA polymerase delta 1, catalytic subunit) pages
Journal article
Domingo E., (2019), Atlas of Genetics and Cytogenetics in Oncology and Haematology
POLE (DNA polymerase epsilon, catalytic subunit)
Journal article
Domingo E., (2019), Atlas of Genetics and Cytogenetics in Oncology and Haematology
Targeted next generation sequencing reveals a common genetic pathway for colorectal cancers with chromosomal instability and those with microsatellite and chromosome stability
Journal article
Ham-Karim HA. et al, (2019), Pathology-Research and Practice, 152445 - 152445
The evolutionary landscape of colorectal tumorigenesis.
Journal article
Cross W. et al, (2018), Nat Ecol Evol, 2, 1661 - 1672
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.
Journal article
Domingo E. et al, (2018), Lancet Gastroenterol Hepatol, 3, 635 - 643
Prognostic markers for colorectal cancer: estimating ploidy and stroma.
Journal article
Danielsen HE. et al, (2018), Ann Oncol, 29, 616 - 623
Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent
Journal article
Domingo E. et al, (2018), Lancet Gastroenterology and Hepatology, 3
Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution.
Journal article
Baker A-M. et al, (2017), Nat Commun, 8
Pharmacoproteomic characterisation of human colon and rectal cancer.
Journal article
Frejno M. et al, (2017), Mol Syst Biol, 13